As per the WHO, in 2019, an estimated 262 million people worldwide were affected by asthma and caused nearly 461,000 deaths. Asthma is categorized on the basis of severity, symptoms, and triggers. childhood asthma, adult-onset asthma, allergic asthma, exercise-induced asthma, occupational asthma, non-allergic asthma are some of the most common types of asthma.
It is observed that the high cost of treatmnet, lack of awareness, limited access to quality care, and medication are some of the key issues faced by asthma patients. To fulfill the unmet need at the therapeutics front, at present, some of the key companies such as Amgen, AstraZeneca, GSK, Regeneron, and others are actively working on the development of therapies for asthma. The launch of the emerging therapies is expected to provide better healthcare outcomes to the affected patients. For more details, visit: Asthma Diagnosis, Key Companies, and Treatment Options